Ovarian cancer is a serious gynecological malignancy, often called the “silent killer” because it frequently shows vague symptoms until advanced stages. At Sunrise Hospital, Delhi, we provide comprehensive ovarian cancer care, including laparoscopic staging, radical hysterectomy, bilateral salpingo-oophorectomy (BSO), omentectomy, lymphadenectomy, and chemotherapy. Our expert gynecologic oncology team ensures better survival outcomes, minimal blood loss, and shorter hospital stays for patients across India.

Ovarian cancer occurs when abnormal cells in the ovary grow uncontrollably, forming tumors that may spread to other pelvic or abdominal organs. It is the seventh most common cancer among women worldwide and is associated with significant morbidity due to late detection.

Types of Ovarian Cancer

• Epithelial Ovarian Cancer – The most common form, accounting for 80–90% of ovarian cancers, arises from the ovarian surface epithelium.
• Germ Cell Tumors – Rare, usually affecting younger women, originating from egg-producing cells.
• Stromal Tumors – Involve hormone-producing cells and are uncommon.

Who is at Risk?

Several factors can increase a woman’s risk of developing ovarian cancer:

• Advancing age: Most cases occur after menopause.
• Infertility: Women who have never had children may face higher risk.
• Endometriosis: Chronic inflammation in ovarian tissue can predispose to malignancy.
• Talcum powder exposure: Long-term use in the perineal area may increase risk.
• Genetic susceptibility: Mutations in BRCA1 or BRCA2 genes account for 8–13% of cases.
• Family history: Having first-degree relatives with ovarian or breast cancer increases risk.

Recognizing these risk factors is crucial for early screening and timely intervention.

Ovarian cancer often progresses silently. Early detection is challenging due to non-specific symptoms, but awareness can make a difference. Common warning signs include:

• Abdominal bloating or swelling – Persistent abdominal enlargement is one of the earliest symptoms.
• Pelvic or abdominal pain – Discomfort or cramping that doesn’t go away.
• Early satiety – Feeling full quickly after meals.
• Urinary urgency or frequency – Changes in bladder habits may indicate pressure from tumors.
• Gastrointestinal complaints – Constipation, indigestion, or nausea.
• Fatigue – General tiredness due to systemic effects of cancer.

Studies indicate that most women recall experiencing symptoms before diagnosis. Therefore, high clinical suspicion is essential for early detection.

Ovarian cancer is influenced by a combination of genetic, environmental, and lifestyle factors.

Advancing Age

The risk increases significantly after age 50, emphasizing the need for vigilance in postmenopausal women.

Infertility and Reproductive History

Women who have never been pregnant or experienced infertility may have a slightly higher risk.

Endometriosis

Chronic inflammation in ovarian tissue can promote malignant transformation.

Talcum Powder Exposure

Some studies suggest that regular talc application to the perineum may increase ovarian cancer risk.

Genetic Susceptibility

Mutations in BRCA1 and BRCA2 genes significantly raise the likelihood of developing ovarian cancer. Genetic counseling and testing are recommended for high-risk women.

Family History

A close relative with ovarian or breast cancer warrants more vigilant monitoring and potential early screening.

Early detection of ovarian cancer is notoriously difficult. Routine pelvic examinations are not effective for screening, and major guidelines (ACS, ACOG, SGO, NCCN) do not recommend general population screening.

Screening for High-Risk Women

Women with BRCA mutations or strong family history may benefit from:

• Transvaginal ultrasound (TVUS) – Detects ovarian masses and abnormalities.
• CA125 blood test – Elevated in ~90% of epithelial ovarian cancers, but may remain normal in 50% of early-stage cases and falsely elevated in 2–3% of postmenopausal women without cancer.

Definitive Diagnosis

Surgical evaluation is required for a conclusive diagnosis:

• Laparoscopy – Minimally invasive, reduces tumor spillage, and aids in staging.
• Frozen section diagnosis – Allows real-time confirmation of malignancy during surgery.
• Surgical staging – Mandatory for determining disease extent and planning therapy.

Early diagnosis through high-risk screening, awareness of vague symptoms, and expert surgical assessment can dramatically improve outcomes.

Surgery is the cornerstone of ovarian cancer treatment. Sunrise Hospital provides laparoscopic staging and complete surgical management tailored to the patient’s disease stage.

Early Stage Ovarian Cancer

• TLow risk (IA/IB, grade 1) – Total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO)
• High risk (IA/IB grade 2–3; IC, IIA–IIC) – TAH + BSO + adjuvant chemotherapy (carboplatin + paclitaxel)

Advanced Ovarian Cancer

• Stage III with optimal cytoreduction – Maximal surgical debulking + combination chemotherapy.
• Stage IV or suboptimal disease – Cytoreduction + chemotherapy

Surgical Procedures Performed at Sunrise Hospital

• Radical hysterectomy
• Bilateral salpingo-oophorectomy (BSO)
• Omentectomy
• Pelvic and para-aortic lymphadenectomy
• Laparoscopic staging surgery for minimal invasion

Optimal cytoreduction, defined as residual tumor ≤1 cm or no visible tumor, significantly improves overall survival (47–66 months vs 33–36 months for suboptimal surgery).

Chemotherapy is critical, especially for high-risk or advanced ovarian cancer.

• Standard IV chemotherapy: Carboplatin + paclitaxel
• Intraperitoneal chemotherapy: Cisplatin + paclitaxel in selected patients
• Interval cytoreductive surgery – Surgery performed after initial chemotherapy in patients unsuitable for upfront surgery

75–80% of patients respond to chemotherapy initially, but resistance may develop over time. Multidisciplinary management ensures personalized treatment plans.

Achieving optimal cytoreduction is a key predictor of survival:

• No visible tumor yields the best outcomes
• Expert surgical centers have a ≥75% optimal cytoreduction rate
• Patients with optimal cytoreduction show improved response to chemotherapy, disease-free survival, and overall survival

Surgical Procedures Performed at Sunrise Hospital

• Considered for patients who cannot undergo optimal primary surgery
• Reduces tumor burden before systemic chemotherapy

Recurrent disease management depends on:

• Disease-free interval
• Number of recurrence sites
• Feasibility of cytoreduction to minimal residual disease

Surgical debulking may benefit select patients, while chemotherapy remains the standard for most.

Sunrise Hospital offers advanced, patient-focused ovarian cancer care:

• Laparoscopic staging & complete surgical management
• Radical hysterectomy, BSO, omentectomy, lymphadenectomy
• Minimally invasive surgery → lesser blood loss, shorter hospital stay
• Expert multidisciplinary team → gynecologic oncologists, medical oncologists, radiologists
• Advanced chemotherapy protocols → tailored to early and advanced stages

Our approach ensures better overall survival and quality of life for every patient.

Ovarian cancer requires early awareness, accurate diagnosis, and expert management. At Sunrise Hospital, Delhi, we combine advanced surgical techniques, laparoscopic staging, and modern chemotherapy protocols to provide comprehensive care for patients. By focusing on optimal cytoreduction, minimally invasive surgery, and multidisciplinary treatment, we aim to improve survival outcomes and quality of life for all ovarian cancer patients.

Contact Sunrise Hospital today to schedule a consultation with our gynecologic oncology experts and take the first step toward effective ovarian cancer management.